Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Accuro Technologies is a private Canadian medical device company developing and commercializing devices intended to improve procedural care. Its lead product, Arthrotap, is a dual-sided intra-articular injection device designed to enable aspiration and injection with the same device, with the goal of reducing needle sticks and simplifying joint injection workflows. The company also describes a broader device pipeline that includes Arthrotap with Indicator, needle sensor technology, and an advanced syringe concept. Accuro appears to operate as an early-stage medtech developer rather than a therapeutics company, with activity centered on engineering, prototyping, testing, regulatory clearance, and product launch preparation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Accuro.